Abstract: The invention relates to a compound according to general formula (I), which acts as a bradykinin (BK) B2 receptor antagonist; to a pharmaceutical composition containing one or more of the compound(s) of the invention; to a combination preparation containing at least one compound of the invention and at least one further active pharmaceutical ingredient; and to uses of said compound(s), including the use as a medicament.
Type:
Grant
Filed:
January 18, 2022
Date of Patent:
November 21, 2023
Assignee:
PHARVARIS NETHERLANDS B.V.
Inventors:
Christoph Gibson, Joern Saupe, Horst-Dieter Ambrosi, Lars Ole Haustedt
Abstract: The invention relates to a compound according to general formula (I), which acts as a bradykinin (BK) B2 receptor antagonist; to a pharmaceutical composition containing one or more of the compound(s) of the invention; to a combination preparation containing at least one compound of the invention and at least one further active pharmaceutical ingredient; and to uses of said compound(s), including the use as a medicament.
Type:
Grant
Filed:
September 25, 2020
Date of Patent:
March 1, 2022
Assignee:
PHARVARIS NETHERLANDS B.V.
Inventors:
Christoph Gibson, Joern Saupe, Horst-Dieter Ambrosi, Lars Ole Haustedt
Abstract: The invention relates to a compound according to general formula (I), which acts as a bradykinin (BK) B2 receptor antagonist; to a pharmaceutical composition containing one or more of the compound(s) of the invention; to a combination preparation containing at least one compound of the invention and at least one further active pharmaceutical ingredient; and to uses of said compound(s), including the use as a medicament.
Type:
Grant
Filed:
April 28, 2020
Date of Patent:
November 17, 2020
Assignee:
Pharvaris Netherlands B.V.
Inventors:
Christoph Gibson, Joern Saupe, Horst-Dieter Ambrosi, Lars Ole Haustedt